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ARSTRACT 
Objectives: Published data suggest that Streptococcus pneu- 
moniae, non-typhi Salmonella species, and Mycobacterium 
tuberculosis are the predominant causes of bloodstream infec- 
tion (BSI) in hospitalized populations in sub-Saharan Africa. 
This study was conducted during the wet season to ascertain 
the etiology and prevalence of BSI among febrile inpatients in 
a hospital where the dry season BSI profile in a similar study 
population had already been documented. 
Methods: In the period from March to May 1998, consecutive 
febrile (>37.5” C) adult (2 14 y) patients presenting to a Malawi 
hospital were enrolled after providing informed consent. Fol- 
lowing clinical evaluation, blood was drawn for culture (bacte- 
ria, mycobacteria, and fungi), human immunodeficiency virus 
(HIV) testing, and malaria smears. 
Results: Of 238 enrolled patients, 173 (73%) were HIV-positive 
and 67 (28%) had BSI. The predominant wet season BSI 
pathogens were non-typhi Salmonella species (41%), M. tuber- 
cu/osis (19%) and Cryptococcus neoformans (9%) (cf. the pre- 
dominant dry season pathogen was S. pneumoniae). 
Mycobacteremia was more likely in HIV-positive than in HIV- 
negative patients (13/I 73 vs. O/65; P < 0.05). A logistic regres- 
sion model yielded clinical predictors of BSI that included 
chronic fever, oral candidiasis, or acute diarrhea. 
Conclusion: Pathogens causing BSI in febrile inpatients in a 
Malawi teaching hospital vary by season. Season- and coun- 
try-specific studies, such as this one, provide data that may 
facilitate empirical therapy of febrile illnesses whose etiologies 
vary by season. 
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Whoever wishes to investigate medicine proper& should 
proceed thus: in the first place to consider the seasons 
of the yea? and what eflects each of them produces. 
Hippocrates (460? - 377 BC) 
Despite this ancient admonition, little has been published 
about the seasonal&y of bloodstream infection (BSI),’ and 
nothing from developing countries where resources for 
diagnosis and treatment of life-threatening infections are 
limited. Without effective microbiology services, deci- 
sions to treat infections often are based on presumptive 
diagnoses. Given the limited availability of antimicrobial 
agents, it is essential that clinicians in developing coun- 
tries be provided reliable information regarding the most 
likely pathogens that are associated with commonly diag- 
nosed infections, and the susceptibilities of these 
pathogens to available antimicrobials. 
Previous studies of BSI in hospitalized adults in sub- 
Saharan Africa have demonstrated varying distributions of 
BSI pathogens.*-’ Most of these studies used limited lab- 
oratory methods, were conducted during one seasonal 
cycle, or included cumulative annual data that did not 
permit investigators to determine whether the distribu- 
tion of BSI pathogens varies by season. This report pre- 
sents a prospective evaluation of BSI in febrile inpatients 
in a teaching hospital in sub-Saharan Africa where it had 
already been established that the predominant pathogens 
causing BSI during the dry season are Streptococcus pneu- 
moniae and Mycobacterium tuberculosis.’ 
MATERIALS AND METHODS 
Study Area 
Lilongwe Central Hospital (LCH) is the largest govern- 
ment regional medical center in central Malawi. It has 
approximately 300 beds and provides services to a 
patient catchment area of 230,000 citizens. During the 
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wet season, there are approximately 8 to 15 admissions 
to the medical service per day, and over 50% of these 
patients have fever. Less than 1% of newly admitted adult 
patients with fever have blood cultures performed. The 
most common diagnoses made in adult patients admitted 
to LCH with fever are malaria, tuberculosis, diarrhea, sep- 
sis, or human immunodeficiency virus type 1 (HIV-l) 
infection.* The microbiology facilities at LCH are limited 
to only gram stains routinely performed on sputum or 
urine specimens, and examination of blood smears for 
malaria. Thus, many of the above admission diagnoses are 
never confirmed. 
Patients 
In the period between March 22 and May 6, 1998 (study 
period), all febrile (axillary temperature 237.5”C within 
12 hr of admission) adults (214 y) presenting to the LCH 
medical service, regardless of symptoms, were evaluated 
by clinical officers supervised by one of the study’s prin- 
cipal investigators. After providing informed consent, 
patients were interviewed and examined. The data from 
the history and physical examination were recorded on 
standardized assessment forms and included demo- 
graphics, history of acute and chronic symptoms, antimi- 
crobial therapy during the week before admission, and 
clinical outcome (whether patients were discharged or 
died). Fever, cough, weight loss, and diarrhea were 
deemed chronic if present for more than 1 month. 
Next, venous blood was drawn for culture, blood 
count, HIV-l testing, and preparation of malaria smears. 
All patients received HIV-l pretest counselling. Human 
immunodeficiency virus type I test results were reported 
to the physician in charge of the patient’s inpatient care; 
post-test counselling was provided to study patients with 
confirmed HIV-l infection. 
Blood Cultures and Malaria Smears 
Five milliliters of blood were inoculated into each of a 
pair of BACTEC TM Myco/F Lytic (MFL) blood culture bot- 
tles designed for use in the BACTEC 9000 series auto- 
mated blood culture instruments (Becton Dickinson 
Microbiology Systems, Cockeysville, MD), another 10 mL 
were added to an ISOLATORTM 10 (Isolator) tube 
(Warnpole Laboratories, Cranbury, NJ). The Isolator tube 
was processed according to the manufacturer’s recom- 
mendations and portions of the lysis-centrifugation con- 
centrate were cultured for mycobacteria in a 
Septi-ChekTM AFB biphasic blood culture bottle (Becton 
Dickinson), and for fungi on inhibitory mold agar (IMA) 
slants, as previously described.8 All blood culture bottles 
and agar slants were incubated aerobically at 35°C. The 
MFL blood culture bottles were examined manually for 
growth, using a handheld ultraviolet lamp to detect flu- 
orescence of the indicator at the bottom of the bottle. 
This was performed daily during the first week and then 
once weekly for a total of 8 weeks. Septi-Chek AFB bot- 
tles were examined once weekly for a total of 8 weeks 
or until growth was observed. The IMA slants were read 
macroscopically daily during the first week, then weekly 
for 4 weeks or until growth was observed. Preliminary 
identification of bacteria and fungi was made on site 
using standard microbiologic tests. 
All blood culture bottles and all bacteria, fungi, or 
mycobacteria that were isolated from blood cultures at 
the study site were transported to the Clinical Microbi- 
ology Laboratory at Duke University Medical Center, 
where mycobacteria and fungi cultures were processed 
and the identities of bacteria and fungi isolates were con- 
firmed. Mycobacterium tuberculosis complex and 
Mycobacterium avium complex were identified using 
DNA probes (AccuPROBE; Gen-Probe, San Diego, CA) and 
biochemical tests. 
The blood culture methods, the volume of blood 
inoculated into the MFL vial, and onsite microbiologic 
methods for identification of gram-positive and gram-neg- 
ative organisms, mycobacteria, and yeasts were identical 
to those used during the wet season study.* In addition, 
for both wet and dry season studies, confirmatory tests 
at Duke University Medical Center were performed by the 
same persons. 
Thick blood smears were prepared for each enrolled 
study patient. Smears were stained using a modified 
Wright stain and examined microscopically for the pres- 
ence of malaria parasites. In addition, smears were pre- 
pared from the blood of a randomly selected group of 
adult outpatient clinic attendees, who were afebrile and 
who were not deemed to have underlying infection. 
HIV- 1 Testing and Antimicrobial Susceptibility 
Testing 
Serum samples were assayed in batches using the SUDS 
HIV-l and -2 enzyme-linked immunosorbent assay (ELISA) 
test kits (Murex Diagnostics Inc., Norcross, GA). Positive 
HIV-l ELISA results were repeated before reporting results 
to patients or physicians. 
Antimicrobial susceptibility testing was performed 
at Duke University Medical Center according to the rec- 
ommendations of the National Committee for Clinical 
Laboratory Standards. 9,10 Susceptibilities of gram-negative 
organisms to standard antimicrobial panels were tested 
using the Microscan’ Walkaway (Baxter Diagnostics Inc., 
Deerfield, IL). Other susceptibilities were determined 
using standard disk-diffusion methods. The susceptibilities 
of M. tuberculosis isolates were determined using the 
BACTEC radiometric method (Becton Dickinson Diag- 
nostics Instrument Systems, Sparks, MD). 
Seasons and Rainfall 
In Malawi, the wet season is the period between Decem- 
ber and April; the dry season runs from May to Novem- 
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Table 1. Clinical Characteristics of Study Patients (n = 238), 
Lilongwe Central Hospital, Malawi, March-May, 1998 
Clinical Characteristic 
History of previous antibacterial therapy 
History of previous antituberculous therapy 
History of previous antimalarial therapy 
Family history of cough 
Acute symptoms (<I wk) 
Chills 
Cough 
Shortness of breath 
Diarrhea 
Skin lesions 
Chronic symptoms (21 mo) 
Fever 
Cough 
Diarrhea 
Skin lesions 
Cachexia 
Physical findings 
Oral thrush 
Jaundice 
Lymphadenopathy 
Hepatomegaly 
Splenomegaly 
BCG scar present 
Abnormal chest physical findings 
Abnormal central nervous system findings 
BCG = bacille Calmette-GuBrin. 
Frequency n (%) 
78 (32) 
21 (9) 
96 (40) 
28 (12) 
78 (33) 
117 (49) 
100 (42) 
78 (33) 
10 (4) 
90 (38) 
69 (29) 
16 (7) 
8 (3) 
92 (39) 
43 (18) 
6 (3) 
22 (9) 
15 (6) 
15 (6) 
166 (70) 
78 (33) 
47 (20) 
ber. Records with details of the daily levels of rainfall in 
Lilongwe during 1997 and 1998 were obtained from a 
local agricultural company. These rainfall data were 
obtained from daily onsite measurements taken at a fixed 
location within 5 km of LCH. 
Data Analysis and Statistics 
The data from clinical assessment forms and results from 
blood cultures, malaria smears, and HIV-l serology were 
entered into a computer and analyzed using Epi Info 
computer software.’ * The chi-squared test with Yates’ 
correction or Fisher’s exact test, where appropriate, were 
used to compare categoric variables. Continuous vari- 
ables were compared using the Wilcoxon two-sample 
test. Relative risks (RR), odds ratios (OR), and 95% con- 
fidence intervals (CI) were calculated. Multivariate analy- 
sis using logistic regression was performed using SAS 
statistical software for personal computer (SAS Institute 
Inc., Gary, NC). Results from this study were compared 
to published BSI data obtained during the LCH 1997 dry 
season.’ 
RESULTS 
During the study period, 238 consecutive, febrile adults 
were enrolled in the study. The median axillary temper- 
ature was 38.9”C (range, 37.5-42.O”C). The median age 
of study patients was 29 years (range, 14-61 y); 137 (58%) 
patients were female. The clinical characteristics of study 
patients are presented in Table 1. 
Prevalence of Bloodstream infection, HIV-l, and 
Malaria 
Sixty-seven (28%) study patients had BSI; only one of 
these BSIs was polymicrobial (i.e., > 1 pathogen). Non- 
typhi Salmonella species, M. tuberculosis, or Cryptococ- 
cus neoformans were the three most common BSI 
pathogens, representing 41%, 19%, and 9% of all isolated 
pathogens, respectively. Only one Spneumoniae was iso- 
lated. These results varied from those reported for the 
1997 dry season (Table 2). 
Of the 238 study patients, 173 (73%) were HIV-l pos- 
itive; of the 67 patients with BSI, 55 (82%) were HIV-l- 
positive. Malaria smears were prepared for 231 study 
patients and 73 afebrile outpatient adult attendees. The 
rate of malaria parasitemia was significantly higher in the 
study-patient group than in the afebrile group from the 
outpatient clinic (72/231 [31%] vs. lo/73 [14%], RR = 
2.3; 95% CI = 1.2-4.2; P < 0.01). Malaria was the pre- 
sumptive diagnosis made by clinicians in 114 (48%) study 
patients. Of these 114 patients, 64 (56%) were presump- 
tively treated for malaria despite having negative blood 
smears. Of these 64 patients, 22 (34%) had BSI; all but 
one (Spneumoniae) of these BSI pathogens were gram- 
negative bacteria. 
Table 2. Distribution of Bloodstream Pathogens, Lilongwe Central Hospital, Malawi: Wet Season vs. Dry Season 
Pathogen Wet Season, 1998 (N = 68) n (%) Dry Season, 1997 (N=73) * n (%) P-Value 
Non-typhi Salmonella species 28 (41 .O) 
Mycobacterium tuberculosis 
11 (15.0) <O.OOl 
13 (19.0) 
Cryptococcus neoformans 
19 (26.0) NS 
6 (9.0) 
Other Mycobacterium species 
4 (5.5) NS 
0 NS 
Escherichia co/i 
4 (5.5) 
3 (4.0) 
Salmonella typhi 
3 (4.0) NS 
Staphylococcus aureus 
3 (4.0) 2 (3.0) NS 
2 (3.0) 0 
Acinetobacter lwoffi 
NS 
0 
Other fungi+ 
2 (3.0) NS 
2 (3.0) 0 
Proteus mirabilis 
NS 
1 (1.5) 0 
Streptococcus pneumoniae 
NS 
Rhodococcus equi 
1 (1.5) 24 (33.0) <0.0001 
1 (1.5) 0 NS 
*Archibald LK. et a/,2 
+One Crypiococcus laurentii and one Candida tropicaks. 
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Table 3. Relation between HIV-l Status and Bloodstream Infection, Lilongwe Central Hospital, Malawi, March-May 1998 
Pathogen HIV- 7 Status 
Positive N= 173 (%) Negative N=65 (%) Relative Risk (C/J* P-Value 
Any bloodstream infection 56 (32.0) 11 (18) 1.7 (1.0-3.0) 0.04 
Mycobacteria 13 (7.5) 0 (0) Undefined 0.01 
Bacteria 36 (21 .O) 9 (15) 1.4 (0.7-2.6) NS 
Fungi 7 (4.0) 2 (3) 1.3 (0.3-6.2) NS 
*Cl = 95% confidence interval 
Clinical Predictors for Bloodstream Infection 
Patients with HIV-l infection were significantly more 
likely than those without HIV-l infection to have M. tuber- 
culosis BSI (Table 3); risk of bacteremia or fungemia were 
not associated with patient HlV-1 status. There was no sig- 
nificant association between the presence of bacille Cal- 
mette-Gdrin (BCG) scars and M tuberculosis BSI. 
Previous Antimicrobial Therapy and Presence of 
Bloodstream Infection 
Logistic regression analysis revealed that oral can- 
didiasis, chronic fever, and acute diarrhea were indepen- 
dently associated with BSI (Table 4). Bloodstream 
infections were found in 37% (51/137) of patients with 
one or more of these clinical features compared with 
16% (16/101> of patients without. Thus, the positive pre- 
dictive value for BSI in patients having one or more of 
these clinical features was 37%. 
A history of use of antimicrobial, antituberculous, or anti- 
malarial agents before hospital admission was available for 
221 study patients. For the week preceding hospital 
admission, antimicrobial use was documented in 78 (35%) 
of these patients. Preadmission use of antimalarial and 
antituberculous agents was documented in 96 (43%) and 
21 (10%) patients, respectively There was no association 
between being on any of these therapies on admission 
and presence or absence of mycobacteremia, bacteremia, 
or fungemia. 
Predictors of Inpatient Mortality 
In specific types of BSI, HIV-l infection, history of Outcome data (death or discharge from hospital) were 
chronic cough, and a family history of cough were found available for 199 (84%) of the 238 study patients. The 
to be independent risk factors for mycobacteremia (see overall inpatient mortality rate in these patients was 24% 
Table 4). Mycobacteremia was found in 7% (13/178) of (47/199). Inpatient mortality was significantly higher in 
patients with one or more of these risk factors compared patients with BSI than in those without BSI (22/53 [420/u] 
with 0% (o/60) of those without. The positive predictive vs. 25/146 [17%]; P < 0.001). When stratified by type of 
value for mycobacteremia in patients having one or more BSI, 37% of patients with bacteremia, 36% of those with 
of these clinical features was 7%. There were four inde- mycobacteremia, and 71% of those with fungemia died 
pendent risk factors for bacteremia: chronic vomiting, in hospital. Although patients with HIV-l infection were 
acute diarrhea, jaundice, and fever over 38.9”C. Bac- more likely to die during hospitalization than patients 
teremia was found in 26% (39/152) of patients with one without HIV-l infection (42048 [28%] vs. 5/51 [lo%], RR 
or more of these risk factors compared with 8% (7/86) = 2.9; 95% CI = 1.2-6.9; P < 0.01) on multivariate analy- 
of patients without risk factors. The positive predictive sis, independent predictors of inpatient mortality were 
value for bacteremia in patients having one or more of presence of any BSI (OR = 3.2; 95% CI = 1.4-7.3; P < 
these risk factors was 26%. O.OOl), altered mental status (OR = 4.3; 95% CI = 1.8-9.8; 
Table 4. Independent Clinical Predictors of Bloodstream Infection in Febrile Adults, Lilongwe Central Hospital, Malawi, March-May 1998 
Tvns of BSI Clinical Predictor Odds Ra tie (Cl) * P-Value . , I - - -  ~~ 
Any BSI (n = 67) Chronic fever 
Oral candidiasis 
Acute diarrhea 
Mycobacteremia+ (n = 13) Chronic cough 
Family history of cough 
Bacteremia (n = 45) Chronic vomiting 
Acute diarrhea 
Jaundice 
Temperature >38.9”C 
Fungemia (n = 9) Chronic cough 
Neck rigidity 
Herpes simplex infection 
*Cl = 95% confidence interval; tall patients with mycobacteremia were HIV-1 -POSitlVe. 
BSI = bloodstream infection. 
3.1 (1.6-6.0) 0.0005 
2.3 (1.1-4.8) 0.03 
2.2 (1.1-4.1) 0.02 
16.4 (2.0-139.0) 0.01 
5.9 (1.4-24.5) 0.01 
8.5 (1.8-40.0) 0.007 
2.7 (1.3-6.0) 0.009 
7.8 (1.2-51.7) 0.03 
2.9 (1.3-6.5) 0.007 
7.4 (1.2-44.2) 0.03 
17.1 (2.8-105.0) 0.002 
29.1 (1.6-542.0) 0.02 
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P = O.OOOl), or presence of chronic symptoms (OR = 
2.7; 95% CI = 1.1-6.3; P < 0.05). 
Antimicrobial Susceptibility Testing 
Of the 28 non-typhi Salmonella species that were iso- 
lated during the wet season, 15 (54%) were S. 
typhimurium, 4 (14%) S. enteritidis, and 9 (32%) were 
other serotypes. All non-typhi Salmonella species and S. 
typhi isolates were susceptible to chloramphenicol and 
ciprofloxacin. However, among the non-typhi Salmonella 
species isolates, there was 64% resistance to trimetho- 
prim-sulfamethoxazole (TMP-SMX) and 73% resistance to 
ampicillin. Resistance to TMP-SMX and ampicillin among 
non-typhi Salmonella species isolates was not associated 
with exposure to antibacterial agents before admission to 
the hospital. All 13 M. tuberculosis isolates were sus- 
ceptible to ethambutol, isoniazid, pymzinamide, rifampin, 
and streptomycin. 
Rainfall 
The mean monthly rainfall in the 1998 wet season dur- 
ing which this study was conducted was 118 mm per 
month. In contrast, the mean monthly rainfall during the 
1997 dry season was less than 1 mm per month. 
DISCUSSION 
The overall BSI rate in a febrile, adult population hospi- 
talized in a large Malawi District General Hospital during 
the 1998 rainy season was 28% and the three most com- 
monly isolated pathogens were non-typhi Salmonella 
species (41%) M. tuberculosis (19x)), and C. neoformans 
(9%). The HIV-l seroprevalence rate in the study popu- 
lation was high (730/u), and the rates of bacteremia, 
mycobacteremia, and fungemia increased as the number 
of specific clinical predictors for each of these types of 
BSI increased. A previous study of an adult inpatient pop- 
ulation at the same hospital during the 1997 dry season 
used the same case definition (fever), microbiologic meth- 
ods, and blood culture inoculating volume, and showed 
similar BSI (28%) and HIV-l seroprevalence (76%) rates2 
However, the BSI pathogens most commonly isolated in 
the dry season study were Spneumoniae (33%) and M. 
tuberculosis (26%). 
Although seasonal variations in disease occurrence, 
especially for various infectious diseases, have been estab- 
lished by epidemiologists and clinicians over the years, 
few data have been documented for seasonal variation 
of BSI. In 1983, Flournoy and colleagues observed a sea- 
sonal pattern for Spneumoniae BSI in a United States 
institution-a monophasic pattern that peaked from 
December to April.’ A search of the medical literature 
has revealed no published data that describe seasonal 
occurrence of non-typhi Salmonella bacteremia in devel- 
oped or lesser developed countries. Suggested reasons 
for seasonal occurrence of BSI include variation in viru- 
lence of bacterial pathogens; host susceptibility; patient 
demographics and behavior; environmental factors, such 
as weather; or occurrence of underlying diseases, such 
as HIV-l infection.’ 
Previous studies in sub-Saharan Africa either were 
conducted during one particular season or combined 
data over seasonal cycles.2-‘~‘z Thus, seasonal variation in 
the distribution of BSI pathogens among inpatients in 
subSaharan Africa has not been previously documented. 
The importance of season-specific surveillance is clearly 
illustrated by the different recovery rates despite similar 
culture methods for non-typhi Salmonella and S.pneu- 
moniae in the wet and dry seasons. These two pathogens 
respond to different categories of antimicrobials. In more 
affluent settings, initial empirical therapy would be initi- 
ated to treat a broad spectrum of potential pathogens. 
Then, laboratory tests would be applied to focus treat- 
ment on a specific pathogen. In many developing coun- 
tries, confirmatory laboratory tests are not available or 
the microbiologic methods (e.g., type of media available, 
duration of incubation, requirements for quality control) 
may be inadequate. Where cost or availability prohibits 
the use of multiple antimicrobials, the clinician often is 
compelled to choose one empirical regimen. Thus, the 
patient’s survival may depend on the clinician’s awareness 
of the distribution of potential BSI pathogens. 
To improve patient outcomes and enhance rational 
use of antimicrobials, hospitals in developing countries 
with limited laboratory resources may need to improve 
the accuracy of probable diagnoses and choice of antimi- 
crobials used for initial empirical therapy. Establishing 
comprehensive microbiology laboratories at all hospitals 
in these settings may be inappropriate or unrealistic. A 
better approach would be identification of regional or 
sentinel microbiology laboratories and use of resources in 
these laboratories to conduct cohort-based or “probe” 
studies, such as the authors’ study.* Cohort-based studies 
are conducted as periodic surveys of patients who meet 
simple, objective entry criteria, such as symptoms, signs 
(e.g., fever, diarrhea, rashes, or altered mental status), or 
syndromes. Cohort-based microbiologic surveillance stud- 
ies, such as the authors’ study, focus on quality-controlled 
diagnostic testing with a relatively high positive predictive 
value for infection, such as cultures of blood, cerebrospinal 
fluid, or stool, and may be more feasible and effective than 
continuous, individual, patient-directed laboratory testing 
in providing useful clinical information. In this way, the dis 
tribution of pathogens associated with various infections 
and their susceptibilities to available antimicrobials would 
be determined. These data could then be used to facilitate 
selection of the most appropriate agents for empirical 
therapy between study periods. In addition, these studies 
would provide the opportunity to enhance basic clinical 
microbiology capacity in sentinel regional hospitals or 
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laboratories in need of critical public health infrastruc- 
ture. In the authors’ study, available resources were focused 
on obtaining blood cultures in a high-risk patient popu- 
lation using comprehensive methods to detect bacteria, 
mycobacteria, and fungi on site. It was documented that 
a relatively simple but highly efficient blood culture 
method can be effectively applied even in an underde- 
veloped setting. 
Another cost-effective approach to the use of limited 
microbiology resources would be to base blood cultures 
(where resources are available) or empirical therapy on 
clinical predictors or syndromes. The authors’ data sug- 
gest that although the positive predictive value of clini- 
cal predictors for bacteremia, mycobacteremia, or 
fungemia are limited in scope, they are potentially useful 
for the development of therapeutic or diagnostic algo- 
rithms. For example, patients presenting with acute diar- 
rhea, vomiting, jaundice, and a high fever may be 
considered to be at increased risk of acquiring a BSI, 
probably caused by non-typhi Salmonella species, and 
ought to be considered for bacterial blood cultures, where 
these services are available, or treated with an appropri- 
ate empirical regimen. Febrile adult patients with a his- 
tory of chronic cough and a family history of cough may 
be considered at risk of acquiring disseminated M. tuber- 
culosis and should be examined, at least, with a chest 
radiograph and sputum smear. 
Although differences in the prevalence of BSI may 
reflect different rates of HIV-l infection or differences in 
the stage of HIV-1 infection when patients present to the 
hospital, they also reflect the sensitivity of various blood 
culture methods used in these studies, especially for iso- 
lation of mycobacteria. Although the contribution of 
mycobacteremia to acute morbidity may be small, it may 
be necessary to assess whether the relatively large num- 
ber of patients with M. tuberculosis BSI pose a significant 
infectious risk to others in the hospital and in their com- 
munities. The issue of hospitalized patients who do not 
have symptoms or signs of M. tuberculosis infection but 
have disseminated tuberculosis as evidenced by mycobac- 
teremia (occult mycobacteremia) at the time of admis- 
sion has recently been broached,“,‘” but requires further 
study. Identification of clinical predictors of M, tubercu- 
losis BSI may provide an early opportunity to determine 
which patients have a high probability of disseminated 
tuberculosis and therefore should be screened early on 
with chest radiographs and sputum smears. 
Febrile illnesses commonly are responsible for hos- 
pital admission in sub-Saharan Africa2-4~14 and often are 
attributed to malaria.r5 Although malaria parasitemia was 
significantly higher among the wet season study patients 
compared to the dry season study cohort (31% VS. 4%; P 
< O.OOl), clinical malaria was markedly overdiagnosed in 
both seasons.2 In the wet season, 56% of the study 
patients diagnosed with malaria were incorrectly diag- 
nosed. Of these patients incorrectly diagnosed and treated 
for malaria, 34%, in fact, had BSIs caused almost exclu- 
sively by gram-negative organisms. Although malaria is 
an illness of well-known seasonal@, treatment algorithms 
often fail to reflect this.‘“,r7 Resources may be unneces- 
sarily spent on providing empirical therapy at constant 
levels throughout the year for an infection whose etio- 
logic agent varies seasonally. Studies such as this one pro- 
vide location-specific confirmation of such patterns. 
Taking seasonal variations in disease prevalence into con- 
sideration could strengthen therapeutic algorithms for 
hospitalized patients with fever. 
The present study had some limitations. First, only 
one cycle of seasons was assessed. Confirmatory assess- 
ments of seasonal variations in the etiology of BSI in hos- 
pitalized populations may need to be determined over 
several seasonal cycles in some countries. Second, the 
study population had remarkably high rates of HIV-1 sero- 
prevalence. This underscores the potential pitfalls in 
applying these results to other populations that may have 
a lower rate of HIV-l seroprevalence, and the need for 
region-specific studies. Third, the study population had a 
high rate of pre-admission antimicrobial exposure, which 
nonetheless, was still lower than the dry season rate (35% 
wet season vs. 48% dry season; P < 0.01). However, this 
significant seasonal difference in antibacterial exposure 
preceding hospital admission did not appear to signifi- 
cantly affect the percentage recovery of BSI pathogens 
(29% wet season vs. 28% dry season; P = NS). Although 
the data suggest that exposure to antimicrobials before 
hospital admission was not associated with the presence 
or absence of BSI, resistance was documented among the 
non-typhi SalmoneZZa isolates to two antimicrobial agents 
that are commonly prescribed at LCH. Thus, these data 
further emphasize the need to control unrestricted 
antimicrobial use in international settings if emerging 
antimicrobial resistance is to be prevented. 
In resource-poor countries like Malawi, antimicro- 
bials tend to be more readily available in the outpatient 
or inpatient services of the larger general hospitals that 
people attend when they become ill. In Malawi, patients 
are more likely to obtain antimalarials from a community 
clinic for a “fever” before deciding to go to the hospital. 
If their illness were due to malaria, then such treatment 
may likely result in symptom resolution and patients 
would be less likely to attend the hospital. On the other 
hand, patients who present to the hospital with fever 
despite prior antimalarial therapy may, in fact, be less 
likely to have malaria and more likely to have other infec- 
tions, such as bacteremia or pneumonia. This may partly 
explain why the data in the present study showed no 
association between prior treatment with antimalarials, 
antituberculous drugs, or antibacterial agents and pres- 
ence or absence of BSI. When microbiology resources or 
infrastructure in hospitals are not adequate, clinicians 
remain unable to diagnose these other infections. Such 
conditions inevitably result in the overdiagnosis of certain 
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infections, such as malaria, as was seen in the authors’ 
studies. 
In developed countries, confirmation of HIV-l sero- 
logic tests with Western blot molecular technique is stan- 
dard in many laboratories. In contrast, there is continuing 
debate about the usefulness of expensive HIV-l confir- 
matory tests in less-developed countries where the West- 
ern blot often is not used because of its complexity and 
high cost. In hospitals in sub-Saharan Africa and Southeast 
Asia, where 50 to 75% of adults who present to hospital 
with fever may be HIV-l-infected,*-@ it may not be eco- 
nomically feasible to conduct HIV-l confirmatory test- 
ing, though a number of false HIV-positive test results 
would, of course, be expected. Ittiravivongs et al in Thai- 
land, and Urassa et al in Tanzania showed that use of two 
enzyme-linked immunosorbent assay (ELISA) tests to con- 
firm the presence of HIV-l antibodies produces results 
comparable to those of the Western blot.‘8,1T This 
approach to confirming HIV-1 status was used effectively 
in Tanzania, Thailand, and Malawi.2,4.8 Thus, in a country 
with high prevalence rates of HIV-l infection, limited 
financial resources, and inadequate laboratory infra- 
structure, Western blot analysis for confirmation of HIV 
infection may not be necessary. 
Data acquired in the present study are not intended 
for direct extrapolation to other regions or countries. 
Rather, the approach of regional, season-specific,“probe” 
surveillance studies is offered as a model for optimizing 
patient care where routine laboratory tests are not avail- 
able. Selective application of diagnostic laboratory 
resources can provide answers to clinical questions that 
can be generalized within a region, greatly extending the 
effects of limited resources, improving patient care, and 
enhancing the recognition of emerging pathogens or 
antimicrobial resistance. 
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